Pierre Feugier

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

M Leporrier, Sylvie Chevret, Bruno Cazin et al. · Blood · 2001 · 393 citations · Full text

Medicine, Hematology, Oncology +12

Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study

Anne Quinquenel, Luc‐Matthieu Fornecker, Rémi Letestu et al. · Blood · 2019 · 129 citations · Full text

Life Sciences, Genetics, Hematology +10

Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial

Stéphane Leprêtre, Thérèse Aurran, Beatrice Mahé et al. · Blood · 2012 · 92 citations · Full text

Medicine, Oncology, Pharmacology +14

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Erin M. Parry, Ignaty Leshchiner, Romain Guièze et al. · Nature Medicine · 2023 · 83 citations · Full text

Veterinary Medicine, Evolutionary Biology, Hematology +12

ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome

Erin M. Parry, Camilla K. Lemvigh, Stephanie Deng et al. · Cancer Cell · 2023 · 73 citations · Full text

Life Sciences, Immunology, Oncology +16